Shanghai Allist Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai Allist Pharmaceuticals has a total shareholder equity of CN¥4.3B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥4.7B and CN¥379.7M respectively. Shanghai Allist Pharmaceuticals's EBIT is CN¥925.7M making its interest coverage ratio -59.4. It has cash and short-term investments of CN¥2.7B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | -59.4x |
Cash | CN¥2.68b |
Equity | CN¥4.32b |
Total liabilities | CN¥379.72m |
Total assets | CN¥4.70b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688578's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥373.2M).
Long Term Liabilities: 688578's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥6.5M).
Debt to Equity History and Analysis
Debt Level: 688578 is debt free.
Reducing Debt: 688578 has no debt compared to 5 years ago when its debt to equity ratio was 35.1%.
Debt Coverage: 688578 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688578 has no debt, therefore coverage of interest payments is not a concern.